These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1847784)

  • 1. WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.
    Weichman BM; Berkenkopf JW; Grimes D; Heaslip RJ; Sturm RJ; Chang JY
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():477-80. PubMed ID: 1847784
    [No Abstract]   [Full Text] [Related]  

  • 2. WY-50, 295 tromethamine: an orally active 5-lipoxygenase inhibitor with anti-allergic activity.
    Weichman BM; Berkenkopf JW; Chang JY; Heaslip RJ; Kreft AF; Lewis AJ; Musser JH; Grimes D
    Agents Actions Suppl; 1991; 34():201-9. PubMed ID: 1793064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukotrienes and the airways.
    Piper PJ
    Eur J Anaesthesiol; 1989 Jul; 6(4):241-55. PubMed ID: 2547603
    [No Abstract]   [Full Text] [Related]  

  • 6. Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.
    Musser JH; Kubrak DM; Chang J; Lewis AJ
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():536-9. PubMed ID: 2959109
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primates.
    Gundel RH; Torcellini CA; Clarke CC; Desai S; Lazer ES; Wegner CD
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():457-60. PubMed ID: 1825582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leukotriene effects of WY-50,295 tromethamine in isolated guinea pig pulmonary tissues.
    Heaslip RJ; Grimes D; Berkenkopf JW; Ilsemann BA; Sickels BD; Weichman BM
    Eur J Pharmacol; 1993 Apr; 234(2-3):247-54. PubMed ID: 8482329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Amirav I; Pawlowski N
    N Engl J Med; 1991 May; 324(18):1288. PubMed ID: 1849613
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL; Jenkins LP; Rubin EB; Weichman BM
    J Pharmacol Exp Ther; 1994 Jan; 268(1):353-8. PubMed ID: 8301576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():507-10. PubMed ID: 2546393
    [No Abstract]   [Full Text] [Related]  

  • 12. WY-50295 tromethamine: a 5-lipoxygenase inhibitor without activity in human whole blood.
    Carlson R; Kreft A; Hartman D; Tomchek L; Lock Y; Weichman B; Glaser K
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):31-41. PubMed ID: 10319915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078.
    Ishii A; Nakagawa T; Nambu F; Motoishi M; Miyamoto T
    Int Arch Allergy Appl Immunol; 1990; 92(4):404-7. PubMed ID: 1964674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.
    Ramires R; Caiaffa MF; Tursi A; Haeggström JZ; Macchia L
    Biochem Biophys Res Commun; 2004 Nov; 324(2):815-21. PubMed ID: 15474500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
    Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist.
    Howell RE; Jenkins LP; Hartman DA; Gray WB; Kubrak D; Carlson RP; Kreft AF; Grimes D
    Inflamm Res; 1995 Aug; 44 Suppl 2():S170-1. PubMed ID: 8548382
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of the generation and release of leukotrienes from leukocytes.
    Lewis RA
    Prog Clin Biol Res; 1985; 199():163-72. PubMed ID: 2999819
    [No Abstract]   [Full Text] [Related]  

  • 19. ABT-761 attenuates bronchoconstriction and pulmonary inflammation in rodents.
    Bell RL; Harris RR; Malo PE; Bouska JB; Shaughnessy TK; Hulkower KI; Brooks CD; Carter GW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1366-73. PubMed ID: 9067325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of 5-lipoxygenase activity in rat basophilic leukemia cells.
    Wong A; Hwang SM; Cook MN
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():28-34. PubMed ID: 2169181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.